EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances) • Washington
THIS EMPLOYMENT AGREEMENT (this “Agreement”), made and entered into as of the Effective Date (as hereinafter defined), between Amgen Inc., a Delaware corporation (the “Company”), and Edward V. Fritzky (the “Executive”);
AMENDMENT NO. 2 TO THE ENBREL® SUPPLY AGREEMENTSupply Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances)
AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances)
This AMENDMENT NO. 2 (this “Amendment”) is made as of the 17th day of July, 2002, by and between Immunex Corporation, a Washington corporation (“Seller”), and Schering Aktiengesellschaft, a stock corporation organized under the laws of The Federal Republic of Germany (“Purchaser”).
RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances)
On this 15th day of July, 2002 (the “Grant Date”), Amgen Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 1991 Equity Incentive Plan (the “Plan”) has granted to you, the grantee named above, a right to purchase One Hundred Thousand (100,000) shares (the “Shares”) of the $.0001 par value common stock of the Company (“Common Stock”), pursuant to the terms of this Restricted Stock Purchase Agreement (this “Agreement”) and the Plan. Capitalized terms not defined herein shall have the meanings assigned to such terms in the Plan.
ASSET PURCHASE AGREEMENT by and between Immunex Corporation as Seller, and Schering Aktiengesellschaft as Purchaser Dated as of May 2, 2002Asset Purchase Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances) • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of the 2nd day of May, 2002, by and between Immunex Corporation, a Washington corporation (“Seller”), and Schering Aktiengesellschaft, a stock corporation organized under the laws of The Federal Republic of Germany (“Purchaser”).
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 13th, 2002 • Amgen Inc • Biological products, (no disgnostic substances)
This AMENDMENT No. 1 (this “Amendment”) is made as of the 25th day of June, 2002, by and between Immunex Corporation, a Washington corporation (“Seller”), and Schering Aktiengesellschaft, a stock corporation organized under the laws of The Federal Republic of Germany (“Purchaser”).
